| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | 0.0029 | 1 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.004 | 1 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |